Literature DB >> 2697436

Bone marrow transplantation for neuroblastoma: a review of 509 cases. EBMT Group.

G Dini1, T Philip, O Hartmann, R Pinkerton, F Chauvin, A Garaventa, E Lanino, S Dallorso.   

Abstract

Entities:  

Mesh：

Year:  1989        PMID： 2697436

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  9 in total

Review 1.  Stem cell transplantation for neuroblastoma.

Authors:  J D Fish; S A Grupp
Journal:  Bone Marrow Transplant       Date:  2007-11-26       Impact factor: 5.483

Review 2.  Autotransplants with peripheral blood stem cells and clinical results obtained in children: a review.

Authors:  K Leibundgut; A Hirt; A R Lüthy; A Tobler; H P Wagner
Journal:  Eur J Pediatr       Date:  1993-07       Impact factor: 3.183

Review 3.  Neuroblastoma: issues in transplantation.

Authors:  Stephan A Grupp; Shahab Asgharzadeh; Gregory A Yanik
Journal:  Biol Blood Marrow Transplant       Date:  2012-01       Impact factor: 5.742

4.  Silencing of Y-box binding protein-1 by RNA interference inhibits proliferation, invasion, and metastasis, and enhances sensitivity to cisplatin through NF-κB signaling pathway in human neuroblastoma SH-SY5Y cells.

Authors:  Hong Wang; Ruowen Sun; Zuofei Chi; Shuang Li; Liangchun Hao
Journal:  Mol Cell Biochem       Date:  2017-04-05       Impact factor: 3.396

Review 5.  Autologous and allogeneic cellular therapies for high-risk pediatric solid tumors.

Authors:  David Barrett; Jonathan D Fish; Stephan A Grupp
Journal:  Pediatr Clin North Am       Date:  2010-02       Impact factor: 3.278

6.  The use of soybean agglutinin (SBA) for bone marrow (BM) purging and hematopoietic progenitor cell enrichment in clinical bone-marrow transplantation.

Authors:  A Nagler; S Morecki; S Slavin
Journal:  Mol Biotechnol       Date:  1999-04       Impact factor: 2.695

Review 7.  Autologous Stem-Cell Transplantation for High-Risk Neuroblastoma: Historical and Critical Review.

Authors:  Jaume Mora
Journal:  Cancers (Basel)       Date:  2022-05-24       Impact factor: 6.575

8.  Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study.

Authors:  Katherine K Matthay; C Patrick Reynolds; Robert C Seeger; Hiroyuki Shimada; E Stanton Adkins; Daphne Haas-Kogan; Robert B Gerbing; Wendy B London; Judith G Villablanca
Journal:  J Clin Oncol       Date:  2009-01-26       Impact factor: 44.544

Review 9.  High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.

Authors:  Bilgehan Yalçin; Leontien C M Kremer; Elvira C van Dalen
Journal:  Cochrane Database Syst Rev       Date:  2015-10-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.